Status
Conditions
Treatments
About
This study will be an open-label superiority, multicenter, single-blind, controlled randomized clinical trial investing the role of a PVP-I irrigation solution (Surgiphor) in reducing the risk of acute PJI in the 90 days following total hip and knee revision arthroplasty.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
868 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Tiffany Morrison, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal